ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 699150 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 699150; 2) Community: the network communities that were significantly associated with the response to NSC 699150; 3) Molecule: the relationships between components within communities and NSC 699150; 4) MDR: the compounds that were significantly associated with the NSC 699150.

NSC Compound Enrichment Correlation
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.00550789647802199 0.46913884
NSC 645253 Null 0.00550789647802199 0.510731
NSC 67239 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-, triacetate 0.00550789647802199 0.52490523
NSC 727048 11-(3'-Methylaminopropylidene]-5,6-dihydro-5-keto-2,3-dimeth oxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinolin e 0.00550789647802199 0.64272726
NSC 757113 METHOTREXATE(+/-) 0.00550789647802199 0.48768414
NSC 132483 Aminopterin Derivative 0.00559873245069072 0.43550788
NSC 137679 9H-Purine-6(1H)-one, 2-amino-9-.beta.-D-ribofuranosyl-6-seleno- 0.00559873245069072 0.16639651
NSC 145668 Cyclocytidine hydrochloride 0.00559873245069072 0.43779419
NSC 284751 Adenosine, 8-chloro-, cyclic 3',5'-(hydrogen phosphate) 0.00559873245069072 0.43163656
NSC 618939 Camptothecin Derivative 0.00559873245069072 0.49021309
Total:75  Current:14    [First] [Prev] [Next] [Last]